Works by Keunchil Park

Results: 205
    1

    An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations.

    Published in:
    2021
    By:
    • Keunchil Park;
    • Jin-Soo Kim;
    • Joo-Hang Kim;
    • Young-Chul Kim;
    • Hoon-Gu Kim;
    • Eun Kyung Cho;
    • Jong-Youl Jin;
    • Miyoung Kim;
    • Märten, Angela;
    • Jin-Hyoung Kang;
    • Park, Keunchil;
    • Kim, Jin-Soo;
    • Kim, Joo-Hang;
    • Kim, Young-Chul;
    • Kim, Hoon-Gu;
    • Cho, Eun Kyung;
    • Jin, Jong-Youl;
    • Kim, Miyoung;
    • Kang, Jin-Hyoung
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7

    Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild‐Type Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2019, v. 24, n. 8, p. 1095, doi. 10.1634/theoncologist.2018-0695
    By:
    • Sequist, Lecia V.;
    • Gray, Jhanelle Elaine;
    • Harb, Wael A.;
    • Lopez‐Chavez, Ariel;
    • Doebele, Robert C.;
    • Modiano, Manuel R.;
    • Jackman, David Michael;
    • Baggstrom, Maria Quintos;
    • Atmaca, Akin;
    • Felip, Enriqueta;
    • Provencio, Mariano;
    • Cobo, Manuel;
    • Adiwijaya, Bambang;
    • Kuesters, Geoffrey;
    • Kamoun, Walid S.;
    • Andreas, Karen;
    • Pipas, J. Marc;
    • Santillana, Sergio;
    • Cho, Byoung Chul;
    • Park, Keunchil
    Publication type:
    Article
    8

    Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC.

    Published in:
    Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 532, doi. 10.1002/cpdd.427
    By:
    • Tan, Eng‐Huat;
    • Lim, Wan‐Teck;
    • Ahn, Myung‐Ju;
    • Ng, Quan‐Sing;
    • Ahn, Jin Seok;
    • Shao‐Weng Tan, Daniel;
    • Sun, Jong‐Mu;
    • Han, May;
    • Payumo, Francis C.;
    • McKee, Krista;
    • Yin, Wei;
    • Credi, Marc;
    • Agarwal, Shefali;
    • Jac, Jaroslaw;
    • Park, Keunchil
    Publication type:
    Article
    9
    10

    The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group.

    Published in:
    Cancer Research & Treatment, 2025, v. 57, n. 1, p. 39, doi. 10.4143/crt.2024.421
    By:
    • Kim, Bum Jun;
    • Maeng, Chi Hoon;
    • Keam, Bhumsuk;
    • Im, Young-Hyuck;
    • Ro, Jungsil;
    • Jung, Kyung Hae;
    • Im, Seock-Ah;
    • Kim, Tae Won;
    • Lee, Jae Lyun;
    • Heo, Dae Seog;
    • Kim, Sang-We;
    • Park, Keunchil;
    • Ahn, Myung-Ju;
    • Cho, Byoung Chul;
    • Kim, Hoon-Kyo;
    • Kang, Yoon-Koo;
    • Cho, Jae Yong;
    • Yun, Hwan Jung;
    • Nam, Byung-Ho;
    • Zang, Dae Young
    Publication type:
    Article
    11

    Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non–Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial.

    Published in:
    Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1084, doi. 10.4143/crt.2024.084
    By:
    • Shin, Junghoon;
    • Park, Sehhoon;
    • Kim, Kyung Hwan;
    • Shin, Eui-Cheol;
    • Jung, Hyun Ae;
    • Cho, Jong Ho;
    • Sun, Jong-Mu;
    • Lee, Se-Hoon;
    • Choi, Yong Soo;
    • Ahn, Jin Seok;
    • Kim, Jhingook;
    • Park, Keunchil;
    • Shim, Young Mog;
    • Kim, Hong Kwan;
    • Noh, Jae Myoung;
    • Ahn, Yong Chan;
    • Pyo, Hongryull;
    • Ahn, Myung-Ju
    Publication type:
    Article
    12
    13
    14

    Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non–Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis.

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 1, p. 83, doi. 10.4143/crt.2021.1571
    By:
    • Byoung Chul Cho;
    • Dong-Wan Kim;
    • Ullas Batra;
    • Keunchil Park;
    • Sang-We Kim;
    • Cheng-Ta Yang;
    • Pei-Jye Voon;
    • Virote Sriuranpong;
    • K. Govind Babu;
    • Khalid Amin;
    • Yingbo Wang;
    • Paramita Sen;
    • Khemaies Slimane;
    • Sarayut Geater
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21

    Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer.

    Published in:
    Cancer Research & Treatment, 2019, v. 51, n. 1, p. 119, doi. 10.4143/crt.2018.019
    By:
    • Dong-Wan Kim;
    • Hoon-Gu Kim;
    • Joo-Hang Kim;
    • Keunchil Park;
    • Hoon-Kyo Kim;
    • Joung Soon Jang;
    • Bong-Seog Kim;
    • Jin-Hyoung Kang;
    • Kyung Hee Lee;
    • Sang-We Kim;
    • Hun Mo Ryoo;
    • Jin-Soo Kim;
    • Ki Hyeong Lee;
    • Jung Hye Kwon;
    • Jin-Hyuk Choi;
    • Sang Won Shin;
    • Seokyung Hahn;
    • Dae Seog Heo
    Publication type:
    Article
    22
    23
    24

    Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study

    Published in:
    Cancer Research & Treatment, 2017, v. 49, n. 4, p. 937, doi. 10.4143/crt.2016.423
    By:
    • Keunchil Park;
    • Eun Kyung Cho;
    • Maximino Bello;
    • Myung-Ju Ahn;
    • Thongprasert, Sumitra;
    • Eun-Kee Song;
    • Soldatenkova, Victoria;
    • Depenbrock, Henrik;
    • Puri, Tarun;
    • Orlando, Mauro
    Publication type:
    Article
    25
    26

    East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL)

    Published in:
    Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1177, doi. 10.4143/crt.2015.401
    By:
    • Keunchil Park;
    • Joo-Hang Kim;
    • Eun Kyung Cho;
    • Jin-Hyoung Kang;
    • Jin-Yuan Shih;
    • Zimmermann, Annamaria Hayden;
    • Pablo Lee;
    • Alexandris, Ekaterine;
    • Puri, Tarun;
    • Orlando, Mauro
    Publication type:
    Article
    27
    28

    Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial

    Published in:
    Cancer Research & Treatment, 2016, v. 48, n. 2, p. 458, doi. 10.4143/crt.2015.135
    By:
    • Jin Hyoung Kang;
    • Myung-Ju Ahn;
    • Dong-Wan Kim;
    • Eun Kyung Cho;
    • Joo-Hang Kim;
    • Sang Won Shin;
    • Xin Wang;
    • Jong Seok Kim;
    • Mauro Orlando;
    • Keunchil Park
    Publication type:
    Article
    29
    30

    Role of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy.

    Published in:
    Cancer Research & Treatment, 2015, v. 47, n. 4, p. 871, doi. 10.4143/crt.2014.141
    By:
    • Min Kyu Kang;
    • Dongryul Oh;
    • Kwan Ho Cho;
    • Sung Ho Moon;
    • Hong-Gyun Wu;
    • Dae-Seog Heo;
    • Yong Chan Ahn;
    • Keunchil Park;
    • Hyo Jung Park;
    • Jun Su Park;
    • Ki Chang Keum;
    • Jihye Cha;
    • Jun Won Kim;
    • Yeon-Sil Kim;
    • Jin Hyoung Kang;
    • Young-Taek Oh;
    • Ji-Yoon Kim;
    • Sung Hwan Kim;
    • Jin-Hee Kim;
    • Chang Geol Lee
    Publication type:
    Article
    31
    32

    First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920926796
    By:
    • Kim, Seung Tae;
    • Hong, Jung Yong;
    • Park, Se Hoon;
    • Park, Joon Oh;
    • Park, Young Whan;
    • Park, Neunggyu;
    • Lee, Hukeun;
    • Hong, Sung Hee;
    • Lee, Song-Jae;
    • Song, Seong-Won;
    • Kim, Kyung;
    • Park, Young Suk;
    • Lim, Ho Yeong;
    • Kang, Won Ki;
    • Nam, Do-Hyun;
    • Lee, Jeong-Won;
    • Park, Keunchil;
    • Kim, Kyoung-Mee;
    • Lee, Jeeyun
    Publication type:
    Article
    33
    34
    35
    36
    37

    Anthropometric measurements and survival after a prostate cancer diagnosis.

    Published in:
    2018
    By:
    • Sun, Jong-Mu;
    • Lee, Ki Hyeong;
    • Kim, Bong-Seog;
    • Kim, Hoon-Gu;
    • Min, Young Joo;
    • Yi, Seong Yoon;
    • Yun, Hwan Jung;
    • Jung, Sin-Ho;
    • Lee, Se-Hoon;
    • Ahn, Jin Seok;
    • Park, Keunchil;
    • Ahn, Myung-Ju;
    • Farris, Megan S;
    • Courneya, Kerry S;
    • Kopciuk, Karen A;
    • McGregor, S Elizabeth;
    • Friedenreich, Christine M
    Publication type:
    journal article
    38
    39
    40
    41

    Clinical activity of ASP8273 in Asian patients with non‐small‐cell lung cancer with EGFR activating and T790M mutations.

    Published in:
    Cancer Science, 2018, v. 109, n. 9, p. 2852, doi. 10.1111/cas.13724
    By:
    • Murakami, Haruyasu;
    • Nokihara, Hiroshi;
    • Hayashi, Hidetoshi;
    • Seto, Takashi;
    • Park, Keunchil;
    • Azuma, Koichi;
    • Tsai, Chun‐Ming;
    • Yang, James Chih‐Hsin;
    • Nishio, Makoto;
    • Kim, Sang‐We;
    • Kiura, Katsuyuki;
    • Inoue, Akira;
    • Takeda, Koji;
    • Kang, Jin‐Hyoung;
    • Nakagawa, Tomoki;
    • Takeda, Kentaro;
    • Akazawa, Rio;
    • Kaneko, Yuichiro;
    • Shimazaki, Masashi;
    • Morita, Satoshi
    Publication type:
    Article
    42
    43
    44
    45
    46

    Nongastric marginal zone B-cell lymphoma: Analysis of 247 cases.

    Published in:
    American Journal of Hematology, 2007, v. 82, n. 6, p. 446, doi. 10.1002/ajh.20874
    By:
    • Oh, Sung Yong;
    • Ryoo, Baek-Yeol;
    • Kim, Won Seog;
    • Park, Yeon Hee;
    • Kim, Kihyun;
    • Kim, Hyun Jung;
    • Kwon, Jung Mi;
    • Lee, Jeeyun;
    • Ko, Young Hye;
    • Ahn, Yong Chan;
    • Oh, Suk Joong;
    • Lee, Soon Il;
    • Kim, Hyo-Jin;
    • Kwon, Hyuk-Chan;
    • Bang, Soo Mee;
    • Kim, Jung Han;
    • Park, Jinny;
    • Lee, Seung-Sook;
    • Kim, Ho Young;
    • Park, Keunchil
    Publication type:
    Article
    47
    48

    The NHance ® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients.

    Published in:
    Biomedicines, 2021, v. 9, n. 6, p. 665, doi. 10.3390/biomedicines9060665
    By:
    • Aftimos, Philippe;
    • Rolfo, Christian;
    • Rottey, Sylvie;
    • Barthélémy, Philippe;
    • Borg, Christophe;
    • Park, Keunchil;
    • Oh, Do-Youn;
    • Kim, Sang-We;
    • De Jonge, Natalie;
    • Hanssens, Valérie;
    • Zwanenpoel, Karen;
    • Molthoff, Carla;
    • Vugts, Daniëlle;
    • Dreier, Torsten;
    • Verheesen, Peter;
    • van Dongen, Guus A.M.S.;
    • Jacobs, Julie;
    • Van Rompaey, Luc;
    • Hultberg, Anna;
    • Michieli, Paolo
    Publication type:
    Article
    49
    50

    Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies.

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.709877
    By:
    • Passaro, Antonio;
    • de Marinis, Filippo;
    • Tu, Hai-Yan;
    • Laktionov, Konstantin K.;
    • Feng, Jifeng;
    • Poltoratskiy, Artem;
    • Zhao, Jun;
    • Tan, Eng Huat;
    • Gottfried, Maya;
    • Lee, Victor;
    • Kowalski, Dariusz;
    • Yang, Cheng Ta;
    • Srinivasa, BJ;
    • Clementi, Laura;
    • Jalikop, Tejaswini;
    • Huang, Dennis Chin Lun;
    • Cseh, Agnieszka;
    • Park, Keunchil;
    • Wu, Yi-Long
    Publication type:
    Article